The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer.
about
Blood biomarkers for the non-invasive diagnosis of endometriosisSafety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab.Diagnostic value of serum CA125, CA19-9 and CA15-3 in endometriosis: A meta-analysis.P53 and cancer-associated sialylated glycans are surrogate markers of cancerization of the bladder associated with Schistosoma haematobium infection.Serum HE4 is more suitable as a biomarker than CA125 in Chinese women with benign gynecologic disordersRelative Quantification and Higher-Order Modeling of the Plasma Glycan Cancer Burden Ratio in Ovarian Cancer Case-Control Samples.Evaluation of HE4, CA-125, Risk of Ovarian Malignancy Algorithm (ROMA) and Risk of Malignancy Index (RMI) in the Preoperative Assessment of Patients with Adnexal MassIs CA72-4 a useful biomarker in differential diagnosis between ovarian endometrioma and epithelial ovarian cancer?Noninvasive biomarkers of endometriosis: myth or reality?Physiopathological factors affecting the diagnostic value of serum HE4-test for gynecologic malignancies.Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.Diagnostic performance of human epididymis protein 4 compared to a combination of biophysical and biochemical markers to differentiate ovarian endometriosis from epithelial ovarian cancer in premenopausal women.Evaluation of serum CCL18 as a potential biomarker for ovarian cancer.
P2860
Q24185755-34358C42-08D6-48C3-A3C1-52AAB7887AF5Q30490448-A9294E90-6635-4AD4-B386-90F21DD7C080Q34672070-0712579A-3784-419D-8ACC-C7FF972F8597Q34680930-B974DBD6-5AC9-489D-8CB6-1E0324C14A29Q35207172-5085645C-7961-4A1D-8A33-9AE3C83CCE99Q36490028-D86D0375-67EC-4AA3-AD4B-34BB0B099D0BQ37201766-4AD3DFEF-D0E8-4986-80D9-F261F6EEA357Q37221882-ACE19A08-C213-4411-B7C9-DBBAF5AFE4C2Q38197676-BCF95CC9-6429-4D01-A427-447630B4C823Q38991579-11E76A41-2F0B-4116-9BA4-8BF88E81E066Q41006936-6941602B-7891-445E-86E4-B9DBE7A82810Q47244307-4A3D5834-8180-4615-BF86-69A0AA6E9CA7Q48572701-3927FCF2-AA7C-4830-BFFF-661AA4811515
P2860
The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The use of HE4, CA125 and CA72 ...... and epithelial ovarian cancer.
@en
type
label
The use of HE4, CA125 and CA72 ...... and epithelial ovarian cancer.
@en
prefLabel
The use of HE4, CA125 and CA72 ...... and epithelial ovarian cancer.
@en
P2093
P2860
P356
P1476
The use of HE4, CA125 and CA72 ...... and epithelial ovarian cancer
@en
P2093
Adele Ticino
Emanuela Anastasi
Luigi Frati
Paola Storelli
Pierluigi Benedetti Panici
Renato Falzarano
Teresa Granato
P2860
P2888
P356
10.1186/1757-2215-6-44
P577
2013-07-01T00:00:00Z
P5875
P6179
1038491064